Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Discovery Automation - HCS & Cell Based Assays

Gerardo Turcatti's Biography

Gerardo Turcatti, Director, Ecole Polytechnique Federale De Lausanne

Dr. Gerardo Turcatti, directs the academic technological platform, Biomolecular Screening Facility (BSF) at the EPFL (Swiss Federal Institute of Technology) he created in 2006. Previously he co-founded and acted as CTO of Manteia S.A., a Swiss-based company that developed revolutionary high throughput DNA sequencing technologies he transferred to Solexa and Lynx in 2004 (currently commercialized by Illumina Inc.) Prior to this experience, Dr Turcatti had a long multidisciplinary career in R&D divisions of Biotechnology and Pharmaceutical companies with extensive expertise in several Chemical Biology-related disciplines such as Drug Screening, Bio-analytical Chemistry, Receptor Biochemistry, DNA and Protein Chemistry. Dr Turcatti earned his Master in Chemical Engineering at the University of Geneva and his PhD in Chemistry and Biochemistry from the EPFL where he received the award for the best doctoral thesis of the year.

Gerardo Turcatti Image

Digital Holographic Microscopy (DHM): A Label Free Technology for Image-Based Screening Applications

Thursday, 31 May 2012 at 11:15

Add to Calendar ▼2012-05-30 16:00:002012-05-30 17:00:00Europe/LondonACCESS: An Academic Chemical Screening Platform for Switzerland

In order to validate the use of this non invasive interferometric microscopy for monitoring morphological cell changes, we initially focus on cell viability screening assays by comparing the experimental outputs of DHM and standard fluorescence microscopy methods.

Add to Calendar ▼2012-05-30 00:00:002012-05-31 00:00:00Europe/LondonDrug Discovery Automation - HCS and Cell Based